These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24168112)

  • 1. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
    Uehara T; Kanazawa T; Mizukami H; Uchibori R; Tsukahara T; Urabe M; Kume A; Misawa K; Carey TE; Suzuki M; Ichimura K; Ozawa K
    Cancer Sci; 2014 Jan; 105(1):72-80. PubMed ID: 24168112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.
    Kanazawa T; Kommareddi PK; Iwashita T; Kumar B; Misawa K; Misawa Y; Jang I; Nair TS; Iino Y; Carey TE
    Clin Cancer Res; 2009 Apr; 15(7):2222-30. PubMed ID: 19276245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin receptor 2 utilizes distinct signaling pathways to suppress cell proliferation and induce apoptosis in HNSCC.
    Kanazawa T; Misawa K; Misawa Y; Maruta M; Uehara T; Kawada K; Nagatomo T; Ichimura K
    Mol Med Rep; 2014 Sep; 10(3):1289-94. PubMed ID: 25017118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galanin receptor subtypes 1 and 2 as therapeutic targets in head and neck squamous cell carcinoma.
    Kanazawa T; Misawa K; Carey TE
    Expert Opin Ther Targets; 2010 Mar; 14(3):289-302. PubMed ID: 20148716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rap1 mediates galanin receptor 2-induced proliferation and survival in squamous cell carcinoma.
    Banerjee R; Henson BS; Russo N; Tsodikov A; D'Silva NJ
    Cell Signal; 2011 Jul; 23(7):1110-8. PubMed ID: 21345369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
    Stauber RH; Knauer SK; Habtemichael N; Bier C; Unruhe B; Weisheit S; Spange S; Nonnenmacher F; Fetz V; Ginter T; Reichardt S; Liebmann C; Schneider G; Krämer OH
    Oncotarget; 2012 Jan; 3(1):31-43. PubMed ID: 22289787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of galanin and GALR1/2 is associated with early recurrence in head and neck cancer.
    Misawa K; Misawa Y; Kanazawa T; Mochizuki D; Imai A; Endo S; Carey TE; Mineta H
    Clin Exp Metastasis; 2016 Feb; 33(2):187-95. PubMed ID: 26572146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-specific methylation patterns of the GAL and GALR1/2 genes in head and neck cancer: Potential utility as biomarkers for prognosis.
    Misawa K; Mochizuki D; Endo S; Mima M; Misawa Y; Imai A; Shinmura K; Kanazawa T; Carey TE; Mineta H
    Mol Carcinog; 2017 Mar; 56(3):1107-1116. PubMed ID: 27685843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galanin decreases proliferation of PC12 cells and induces apoptosis via its subtype 2 receptor (GalR2).
    Tofighi R; Joseph B; Xia S; Xu ZQ; Hamberger B; Hökfelt T; Ceccatelli S
    Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2717-22. PubMed ID: 18272487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bortezomib induces apoptosis via Bim and Bik up-regulation and synergizes with cisplatin in the killing of head and neck squamous cell carcinoma cells.
    Li C; Li R; Grandis JR; Johnson DE
    Mol Cancer Ther; 2008 Jun; 7(6):1647-55. PubMed ID: 18566236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant methylation inactivates somatostatin and somatostatin receptor type 1 in head and neck squamous cell carcinoma.
    Misawa K; Misawa Y; Kondo H; Mochizuki D; Imai A; Fukushima H; Uehara T; Kanazawa T; Mineta H
    PLoS One; 2015; 10(3):e0118588. PubMed ID: 25734919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galanin mediates tumor-induced immunosuppression in head and neck squamous cell carcinoma.
    de Medeiros MC; Liu M; Banerjee R; Bellile E; D'Silva NJ; Rossa C
    Cell Oncol (Dordr); 2022 Apr; 45(2):241-256. PubMed ID: 35267186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin receptor subtype GalR2 mediates apoptosis in SH-SY5Y neuroblastoma cells.
    Berger A; Lang R; Moritz K; Santic R; Hermann A; Sperl W; Kofler B
    Endocrinology; 2004 Feb; 145(2):500-7. PubMed ID: 14592962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apigenin induces apoptosis via tumor necrosis factor receptor- and Bcl-2-mediated pathway and enhances susceptibility of head and neck squamous cell carcinoma to 5-fluorouracil and cisplatin.
    Chan LP; Chou TH; Ding HY; Chen PR; Chiang FY; Kuo PL; Liang CH
    Biochim Biophys Acta; 2012 Jul; 1820(7):1081-91. PubMed ID: 22554915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteasome inhibitor MG132 potentiates TRAIL receptor agonist-induced apoptosis by stabilizing tBid and Bik in human head and neck squamous cell carcinoma cells.
    Sung ES; Park KJ; Choi HJ; Kim CH; Kim YS
    Exp Cell Res; 2012 Aug; 318(13):1564-76. PubMed ID: 22513214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel role for BDNF-TrkB in the regulation of chemotherapy resistance in head and neck squamous cell carcinoma.
    Lee J; Jiffar T; Kupferman ME
    PLoS One; 2012; 7(1):e30246. PubMed ID: 22276165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct inhibition of interleukin-2 receptor alpha-mediated signaling pathway induces G1 arrest and apoptosis in human head-and-neck cancer cells.
    Kuhn DJ; Dou QP
    J Cell Biochem; 2005 May; 95(2):379-90. PubMed ID: 15779002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of pro-apoptotic protein Bim and down-regulation of anti-apoptotic protein Mcl-1 cooperatively mediate enhanced tumor cell death induced by the combination of ERK kinase (MEK) inhibitor and microtubule inhibitor.
    Kawabata T; Tanimura S; Asai K; Kawasaki R; Matsumaru Y; Kohno M
    J Biol Chem; 2012 Mar; 287(13):10289-10300. PubMed ID: 22270368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin and galanin receptor type 1 suppress proliferation in squamous carcinoma cells: activation of the extracellular signal regulated kinase pathway and induction of cyclin-dependent kinase inhibitors.
    Kanazawa T; Iwashita T; Kommareddi P; Nair T; Misawa K; Misawa Y; Ueda Y; Tono T; Carey TE
    Oncogene; 2007 Aug; 26(39):5762-71. PubMed ID: 17384686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.